Beyond the surface of your skin, eczema, psoriasis and more can majorly impact your self image and intimate relationships.

Phase 3 trial results show roflumilast cream 0.05% to be a safe and effective treatment for children with atopic dermatitis.

Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.